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Abstract: Existing therapeutic strategies for breast cancer are limited by tumor recurrence and
drug-resistance. Antioxidant plant-derived compounds such as flavonoids reduce adverse outcomes
and have been identified as a potential source of antineoplastic agent with less undesirable side
effects. Here, we describe the novel regulation of fatty-acid synthase (FASN), the key enzyme in de
novo fatty-acid synthesis, whereby Vitis vinifera L. cv Vermentino leaf hydroalcoholic extract lowers
its protein stability that is regulated by small ubiquitin-like modifier (SUMO)ylation. The phenolic
compounds characterization was performed by liquid chromatography–mass spectrometry (LC–MS),
whereas mass spectrometry (LC–MS/MS), Western blotting/co-immunoprecipitation (Co-IP) and
RT-PCR, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), clonogenicity assays,
and FACS analysis were used to measure the expression of targets and tumorigenicity.
Vermentino extract exhibits antitumorigenic effects, and we went on to determine that FASN
and ubiquitin-conjugating enzyme 9 (UBC9), the sole E2 enzyme required for SUMOylation,
were significantly reduced. Moreover, FASN was found SUMOylated in human breast cancer
tissues and cell lines, and lack of SUMOylation caused by SUMO2 silencing reduced FASN protein
stability. These results suggest that SUMOylation protects FASN against proteasomal degradation
and may exert oncogenic activity through alteration of lipid metabolism, whereas Vermentino
extract inhibits these effects which supports the additional validation of the therapeutic value of this
compound in breast cancer.
Keywords: antioxidant; breast cancer; FASN; lipid metabolism; polyphenols; protein degradation;
protein stability; ubiquitination; SUMOylation
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1. Background
Breast cancer is the most common malignant cancer in females worldwide [1]. The existing
therapeutic strategies for breast cancer, which include surgery, endocrine therapy, and chemotherapy,
are limited by tumor recurrence and drug resistance [2]. Therefore, novel approaches are needed to
enhance the efficacy of existing therapeutic agents and to improve current clinical protocols.
Adjuvant therapies often attempt to induce cytotoxicity in tumor cells. As tumor cells are known
to rely on alternate metabolic processes, such as de novo fatty-acid synthesis, these pathways harbor
many potential therapeutic targets. In fact, inhibition of fatty-acid synthesis promotes apoptosis
and produces cytotoxicity, which can trigger cell death [3]. A key enzyme in de novo fatty-acid
synthesis is fatty-acid synthase (FASN). FASN catalyzes acetyl coenzyme A (CoA) and malonyl-Co to
form palmitate and a 16-carbon fatty acid [4]. FASN is highly expressed in various breast cancer cell
lines, including hormone-independent lines, such as SKBR-3, and hormone dependent lines, such as
MCF-7 [5]. FASN can be regulated through genetic modulation and/or nuclear maturation of an
isoform of SREBF1 (sterol regulatory element binding transcription factor 1), SREBP1c (sterol regulatory
element binding protein 1c). SREBP1c is a transcription factor that binds the FASN promoter and
increases the transcription rate of FASN [6]. In addition, FASN positively regulates and is regulated by
expression of AKT serine/threonine kinase 1 (AKT1). AKT1 activation protects cells from cell death
following inhibition of fatty-acid synthesis [7].
Another attractive addition to current clinical protocols is recommendation of a diet high in
naturally occurring antioxidants. High consumption of fruits and vegetables containing antioxidative
vitamins, carotenoids, and others small molecules with chemo-preventative activity can be an important
element of primary cancer prevention [8]. Plant pharmacological activity is strongly correlated with
natural antioxidants [9]. Plant-derived antioxidant compounds, such as flavonoids, reduce adverse
outcomes of reactive oxygen and nitrogen species and are a potential source of antineoplastic and
cytotoxic agents with fewer undesirable side effects [10,11]. Several epidemiological studies indicate
that high flavonoid intake is correlated with reduced risk of cancer [12]. In vitro studies demonstrate
that several mechanisms are linked to flavonoid-mediated cytotoxicity, including cell proliferation
inhibition, adhesion, invasion, cell differentiation with simultaneous cell cycle arrest inhibition,
and apoptosis [13,14]. Flavonoids are a sub-group of more than 5000 polyphenolic compounds with
excellent antioxidant properties that are naturally produced in considerable quantities in fruits and
leaves [15]. Oxidation to ortho- and para-quinones are the standard aromatic transformation related to
the presence of the phenolic hydroxyl, which contributes to antioxidant characteristics [16].
Here, we investigated Vitis vinifera L. cv. Vermentino because it is representative of the productive
activities of the Sardinian territory and has a unique phenolic profile compared to other vines
commonly produced in north Italy. The aim of this study was to explore the potential cytotoxicity of
the hydroalcoholic extract of Vermentino leaves as well as the cell signaling pathways implicated in
any potential pharmacological effects.
2. Methods
2.1. Cell Culture and Treatments
The human breast cancer cell lines MCF-7 and SKBR-3 as well as the MCF-12A normal breast
epithelial cell line were obtained from the American Type Culture Collection (ATCC, Rockville,
MD, USA) and were grown according to instructions provided by the ATCC. These epithelial
cell lines were routinely cultured in high glucose Dulbecco’s Modified Eagle Medium (DMEM)
containing 4.5 g/L D-glucose and supplemented with 10% fetal bovine serum and penicillin
(100 U/mL)/streptomycin (100 U/mL) at 37 ◦C under 5% CO2. In this study, cells were exposed
to Vermentino leaf hydroalcoholic extract for 16 and 24 h at concentrations of 100, 200, and 400 µg/mL.
In the experiments described below, cells were treated with 60 µg/mL cycloheximide (CHX) or 0.5 µM
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MG132 (carbobenzoxy-Leu-Leu-leucinal) (Sigma-Aldrich, St. Louis, MO, USA) for 4, 18, and 24 h.
The medium was changed after 15 min of MG132 pretreatment.
2.2. Human Breast Tissue Specimens
Three normal breast tissues and five breast cancer tissues from surgical reductive mammoplasty and
surgical resection of primary breast cancer, respectively, were used (Supplementary Table S1). All tissues
were immediately frozen in liquid nitrogen for subsequent protein extraction. Written informed consent
was obtained from each patient. The study protocol conformed to the ethical guidelines of the 1975
Declaration of Helsinki, as reflected by a prior approval of the study by Cedars-Sinai Medical Center’s
human research review committee.
2.3. Plant Material and Extraction Procedure
Mature leaves of Vitis vinifera L. cultivar Vermentino were collected in August from the apical
portion of plants cultivated in the collection field of the Institute of Sciences of Food Production (ISPA)
in Oristano, Italy. The leaves were immediately put in a portable fridge and cooled to 4 ◦C to be
moved to the ISPA laboratories. There, the leaves were rinsed with tap water, ground into a fine
powder in liquid nitrogen to avoid the degradation of thermolabile compounds, and processed for
polyphenol extraction.
An accelerated solvent extraction was performed following a previously established
methodology [17], with some modifications. An hydroalcoholic (ethanol/water 40%/60%) solvent was
used for the polyphenol extraction from leaf powder. It was performed in triplicate. The leaf powder
was put in contact with the hydroalcoholic solvent for 16 h, thus obtaining a suspension. The suspension
was then centrifuged at 4629 g for 10 min at 4 ◦C (A.L.C.-4227R, A.L.C. s.r.l., Milan, Italy). Only the
supernatant, the hydroalcoholic extract containing the polyphenolic fraction, was frozen at −80 ◦C
and subjected to gaseous nitrogen flow to remove ethanol. Then, it was lyophilized to eliminate all
the water and any ethanol residues. The result was a polyphenolic ethanol-free extract powder used
for analyses and treatments. This extract was suitably diluted in the culture medium to carry out
cell treatments.
The yield of extraction was calculated as the ratio between “the weight of freeze-dried recover”
and “the initial weight of leaf powder used” and expressed as a percentage.
2.4. Phenolic Characterization of Grapevine Extract
2.4.1. HPLC-UV Analysis
Vermentino extract was filtered through 0.2 µm regenerate cellulose membrane syringe filters
(Phenomenex, Torrence, CA, USA). Phenolic compounds were determined by LC–MS (liquid
chromatography–mass spectrometry), according to previously described conditions [18]. A DAD (diode
array HPLC detector) was used at 280, 320, and 520 nm for quantitative analyses. The quantification of
phenolic compounds was performed using the external calibration curves according to commercial
standards; the quercetin 3-O-(6 acetyl) glucoside content was calculated using a quercetin 3-O glucoside
standard curve.
2.4.2. LC-HRMS Analysis
High resolution (HR) MS analyses were performed on a QExactive Orbitrap (Thermo Scientific,
Bremen, Germany) coupled to 1200 series HPLC (Agilent Technologies, Santa Clarita, CA, USA)
equipped with a binary pump, a thermostatic autosampler, and a column oven set to 39 ◦C.
To investigate the secondary metabolite profile, the QExactive was equipped with a heated
electrospray ionization source (HESI), operating in both positive and negative ion mode. The HESI
parameters were spray voltage, 3.2 kV; sheath gas flow rate, 35 (arbitrary units); auxiliary gas,
10 (arbitrary units); sweep gas, 2 (arbitrary units); and capillary temperature, 300 ◦C. Full MS
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acquisition was performed with a resolution power of 70,000 full width at half maximum (FWHM) for
parent ions and 17,500 for the fragment ions with mass accuracy of 5 ppm. The MS parameters were
Automatic Gain Control target 1e6, maximum injection time (IT) 200 ms, and scan range 100–1200 m/z.
The Xcalibur 3.1.66 software (Thermo Scientific, Bremen, Germany) was used to control the instruments
and to process the data. A Gemini C18 (Phenomenex, Torrance, CA, USA; 100 × 2.1 mm, 3 µm,
100Å) was used for chromatographic separation. The flow rate was 0.2 mL/min during a 55 min
period with an injection volume of 5 µL. A linear gradient elution of solvent acetic acid 0.2% (A) and
acetonitrile (B) was applied with the following program: 0 min, 10% B; 0–20 min, 10–20% B; 20–40 min,
20–40% B; and 40–50 min, 40–70% B. The column was equilibrated for 8 min prior to each analysis.
These conditions were adapted from our previous study [18].
Peaks were identified on the basis of their retention time relative to external standards (tR),
UV-VIS spectra (200–650 nm), high resolution mass spectra, phytochemical libraries, and reference
literature. Quantification of the single phenolic compound was performed using calibration curves of
the respective reference compound. When reference compound was not available, the calibration was
based on structurally related molecules.
2.5. Western Blot and Co-Immunoprecipitation (Co-IP)
MCF-7 and SKBR-3 cells were washed with cold phosphate-buffered saline (PBS), and then total
proteins were extracted with 100 uL of radioimmunoprecipitation assay (RIPA) buffer (20 mM Tris-HCl
(pH 7.5), 150 mM NaCl, 1 mM Na2EDTA, 1 mM EGTA, 1% NP-40, 1% sodium deoxycholate) containing
1X protease inhibitors cocktail from Sigma (cat.# P8340; (St. Louis, MO, USA). Immunoprecipitation by
specific antibodies was performed as previously reported [19]. Immunoprecipitated proteins were
subjected to Western blotting (WB) following standard protocols (Amersham BioSciences, Piscataway,
NJ, USA), and the membranes were probed for FASN, AKT1, p-AKT1, small ubiquitin-like modifier
(SUMO)1, SUMO2/3, ubiquitin-conjugating enzyme 9 (UBC9) (Santa Cruz Biotechnology, Dallas, TX,
USA), Ubiquitin (UBC) (Proteintech, Rosemont, IL, USA), caspase-3 (CASP-3), caspase-9 (CASP-9),
and β-actin (Sigma-Aldrich). Bands were detected using an enhanced chemiluminescence detection
system (Millipore Corporation, Billerica, MA, USA). Quantification of relative band intensity was
performed using Quantity One version 4.6.6. basic (Bio-Rad, Hercules, USA), and β-actin was used as
a normalizing factor.
2.6. Real-Time PCR (RT-PCR) Analysis
Total RNA was extracted using a Quick-RNA Kit (Zymo Research, Irvine, CA, USA), according to
the manufacturer’s protocol. The first strand of cDNA was synthesized via reverse transcription by
M-MLV reverse transcriptase (Invitrogen, Carlsbad, CA, USA). Quantitative real-time PCR analysis
was performed using 2 µL of PCR product. TaqMan probes for human FASN (fatty-acid synthase)
and the Universal PCR Master Mix were purchased from ABI (Foster City, CA, USA). Hypoxanthine
phosphoribosyl-transferase 1 (HPRT1) was used as a housekeeping gene. The delta Ct (∆Ct) obtained
was used to find the relative expression of genes, according to the following formula: relative expression
= 2–∆∆Ct, where ∆∆Ct = ∆Ct of respective genes in experimental groups – ∆Ct of the same genes in
control group.
2.7. Cell Viability
The MTT assay (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; Bimake, Houston,
TX, USA) was performed to determine the number of viable cells in culture, as described by the
manufacturer. MCF-7 and SKBR-3 cells were plated into 12-well plates at a density of 1 × 105 cells/well
in 1 mL of DMEM. Cells were then treated with various concentrations of hydroalcoholic extraction of
Vermentino leaves (100, 200, and 400 µg/mL) for 16 and 24 h. Cell proliferation rates were determined by
adding 10 µL of MTT labeling reagent to each well and incubating at 37 ◦C for 30 min. The absorbance
was measured using a plate reader to read the formation of formazan orange dye at 450 nm.
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2.8. Flow Cytometry Assay
To determine the effects of Vermentino extract on cell apoptosis, MCF-7 and SKBR-3 cells were
seeded at a density of 2 × 105 cells per well in a 6-well plate and incubated at 37 ◦C overnight. The cells
were treated with Vermentino extract for 16 or 24 h at concentrations of 100, 200, and 400 µg/mL
and analyzed for apoptosis using flow cytometry. Untreated cells were used as a control (stimulated
cells in the presence of the vehicle, water). Next, cells were trypsinized, washed with cooled PBS,
and then resuspended in 200 µL binding buffer containing 5 µL annexin V-fluorescein isothiocyanate
(FITC) and 10 µL propidium iodide (PI) (Beyotime Institute of Biotechnology, Jiangsu, China) to
be incubated for 15 min in a dark room at room temperature, as suggested by the manufacturer.
A fluorescence-activated cell sorter (FACS) Calibur analyzer (BD Biosciences, San Jose, CA, USA) was
used to perform the analysis.
2.9. Clonogenicity Assay Analysis
Clonogenicity assays were performed to determine the cytotoxic effect of the hydroalcoholic
extract of Vermentino on breast cancer cell lines. Briefly, MCF-7 and SKBR-3 cells were harvested from
a stock culture, and cells were seeded into 12-well plates at a density of 250 cells per well 1 day before
treatment started. The following day, the cells were treated with either the hydroalcoholic extract at
concentrations of 100, 200, or 400 µg/mL and incubated for 16 or 24 h. After approximately 7–10 days
of colony formation, colonies were fixed (paraformaldehyde 4% in PBS) and stained with crystal
violet solution (Cell Biolab SNC, San Diego, CA, USA). The number of colonies were then counted.
The cell-survival fraction was calculated by dividing the number of obtained colonies after treatment
by the number of colonies in the control. Data were represented as number of colonies per well.
2.10. Proteomic Sample Preparation
Fifty micrograms of total proteins were extracted from control and 400 µg/mL Vermentino
hydroalcoholic extract treated samples in SKBR-3 and MCF-7 cell lines. Proteins were denatured in a
solution of 100 mmol/L Tris-HCl, pH 8, and 8 mol/L urea. Samples were then ultrasonicated for 10 min
at intervals of 10 s on and 10 s off (QSonica, Newtown, CT, USA) and centrifuged at 16,000 × g for
10 min at 4 ◦C to remove insoluble pellets. The soluble fraction then was reduced with dithiothreitol
(15 mM) for 1 h at room temperature and alkylated with iodoacetamide (15 mmol/L) for 30 min at
room temperature in the dark. Then, 50 µg protein was diluted to a final concentration of 2 mol/L urea
with 100 mmol/L Tris-HCl, pH 8, and digested overnight on a shaker at 37 ◦C in 3 µg of trypsin/Lys-C
mix (Promega, Madison, WI, USA). Samples were de-salted and cleaned using hydrophobic-lipophilic
balance (HLB) plates (Oasis, HLB 3 0 µm, 5 mg sorbent; Waters Corporation, Milford, MA, USA).
2.11. LC–MS/MS Settings
LC–MS/MS was performed on a Dionex Ultimate 3000 NanoLC connected to an Orbitrap Elite
(Thermo Fisher, Waltham, MA, USA) equipped with an EasySpray ion source. The mobile phase A
was composed of 0.1% aqueous formic acid, and mobile phase B was composed of 0.1% formic acid
in acetonitrile. Peptides were loaded onto the analytical column (PepMap RSLC C18 2 µm, 100 Å,
50 µm i.d. × 15 cm) at a flow rate of 300 nL/min using a linear AB gradient composed of 2–25% A for
185 min, 25–90% B for 5 min, and then an isocratic hold at 90% for 5 min with re-equilibrating at 2% A
for 10 min. The temperature was set to 40 ◦C for both columns. Nano-source capillary temperature
was set to 275 ◦C, and spray voltage was set to 2 kV. MS1 scans were acquired in the Orbitrap Elite at a
resolution of 60,000 full width at half maximum with an automated gain control target of 1 × 106 ions
over a maximum of 500 ms. MS2 spectra were acquired for the top 15 ions from each MS1 scan in
normal scan mode in the ion trap with a target setting of 1 × 104 ions, an accumulation time of 100 ms,
and an isolation width of 2 Da. Normalized collision energy was set to 35%, and one microscan was
acquired for each spectra.
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2.12. Preparative Data Analysis and Peptide Identification Search
The raw MS files were converted to mzXML using MSConvert and searched against the Swiss-Prot
reviewed human FASTA database using the COMET, X! Tandem native, and X! Tandem k-score search
algorithms [20,21]. Precursor and fragment mass tolerance for all of these search algorithms were set to
10 ppm. Cysteine carbamidomethyl was set as a fixed modification, and oxidation of methionine was
set as a variable modification for all search algorithms. A maximum of two missed cleavages for all
tryptic peptides was allowed, and Target-decoy modeling of peptide spectral matches was performed
with PeptideProphet [22]. Peptides with a probability score of >95% from the entire experimental
dataset were imported into Skyline software [23,24] to establish a library for quantification of precursor
extracted ion intensities (XICs). Precursor XICs from each experimental file were extracted against the
Skyline library, and peptide XICs with isotope dot product scores >0.8 and with a minimum of two
prototypic peptides per protein were filtered for final statistical analysis of proteomic differences [25].
Normalization of raw peptide intensities and protein level abundance inference was calculated using
the linear mixed effects model built into the open sources MSSTATs (v3.2.2) software suite [26]. The mass
spectrometry proteomics data were deposited to the ProteomeXchange Consortium via the PRIDE [27]
partner repository with the dataset identifier PXD016748.
2.13. Protein Stability Assay and Half-Life Determination
Cycloheximide (60 µg/mL) was added to SKBR-3 cells in co-treatment with 400 µg/mL of
Vermentino hydroalcoholic extract per well for 4, 18, and 24 h. Protein levels were determined
at indicated time points by Western blotting, as described above, using the anti-FASN antibody.
The relative amount of FASN protein was evaluated by densitometry and normalized to β-actin.
Protein half-life was determined for each experiment using linear regression analysis.
2.14. Proteasomal Activity Assays
Proteasomal activity in MCF-7 and SKBR-3 cell lines was determined with luminescent site-specific
substrates using the Proteasome-Glo assay (Promega), according to the manufacturer’s protocol. Briefly,
cells were plated in 96-well plates at 5 × 103 cells per well and incubated for 24 h. Cells were treated
with Vermentino hydroalcoholic extract, at various concentrations (100, 200, and 400 µg/mL) for 16 and
24 h. Cells were assayed using the Proteasome-Glo kit for chymotrypsin-like (Chym-L), trypsin-like
(Tr-L), and caspase-like (Casp-L) activity, according to the manufacturer’s protocol.
2.15. RNA Interference
To perform the RNAi experiments, six different predesigned small interfering RNAs (siRNAs)
targeting human SUMO1 (#1 sense sequence: 5’-GGAUAGCAGUGAGAUUCACtt-3’, antisense:
3’-GUGAAUCUCACUGCUAUCCtc-5’), (#2 sense sequence 5’-AAGGUGAAUAUAUUAAACUCA-3’
and antisense: 3’-UGAGUUUAAUAUAUUCACCUU-5’), human SUMO2 (#1 sense sequence:
5’-CCACAUCCUGACUACUACCtt -3’, antisense: 3’-GGUAGUAGUCAGGAUGUGGtg-5’), (#2 sense
sequence: 5’-GCUGUUACAUGUAGGGCAATT-3’, antisense: 3’-UUGCCCUACAUGUAACAGCTA
-5’), and human SUMO3 (#1 sense sequence: 5’-GGCAGAUCAGAUUCAGGUUtt -3’, antisense:
3’-AACCUGAAUCUGAUCUGCCtc -5’) were purchased from Ambion (Austin, TX, USA). The siRNA
sequence used for silencing of SUMO3 #2 corresponds to the coding region 161–179 (relative to the
start codon), as previously described [28] (Dharmacon Research, Inc., Boulder, CO, USA). MCF-7
and SKBR-3 cells were cultured in 6-well plate (0.5 × 106 cells/well) and transfected using RNAiMax
(5 µL/well) (Invitrogen, Carlsbad, CA, USA) with SUMO1 siRNA (10 nM), SUMO2 siRNA (10 nM),
or SUMO3 siRNA (10 nM) for 48 h for mRNA or protein expression analyses.
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2.16. Statistical Analysis
Data are expressed as the mean ± standard error of the mean (SEM) or mean ± standard deviation
(SD). Statistical analysis was performed using analysis of variance and Fisher’s exact test and t-test.
Significance was defined by p < 0.05.
3. Results
3.1. Polyphenol Phytochemical Composition
To determine the phenolic profile of Vermentino, we subjected crude leaf extract to HPLC
chromatography. We found that Vermentino leaves contain a mixture of bioactive compounds,
which primarily include quercetin 3-O glucoside and isorhamnetin glucoside (Table 1).
Table 1. Quantification (g/kg ± SD) of phenols in the hydroalcoholic extract of Vermentino grapevine
leaves, obtained by HPLC-UV analysis.
Compound Vermentino(EtOH/H20)
Myricetin 3-O glucoside 0.11 ± 0.01
Eridictyol 7-glucoside 0.25 ± 0.03
Quercetin 3-O rutinoside 0.20 ± 0.02
Quercetin 3-O galactoside 1.29 ± 0.06
Quercetin 3-O glucoside 5.92 ± 0.10
Kaempferol 3-O galactoside 0.68 ± 0.03
Kaempferol 3-O rutinoside 0.08 ± 0.01
Kaempferol 3-O glucoside 1.64 ± 0.07
Quercetin 3-O-(6 acetyl) glucoside 0.19 ± 0.03
Isorhamnetin glucoside 8.00 ± 0.22
Total 18.36
3.2. Vermentino Extract Lowers Cell Viability in Breast Cancer Cell Lines
As phenolic compounds, such as flavonoids, have been shown to induce cytotoxicity in cancer cell
lines, we evaluated cell viability after treatment with Vermentino hydroalcoholic extract. We treated
MCF-7 and SKBR-3 breast cancer cell lines as well as the MCF-12A human breast epithelial cell line and
compared the resulting cytotoxicity. All three cell lines were treated with Vermentino hydroalcoholic
extract in increasing concentrations of 100, 200, and 400 µg/mL for 16 and 24 h. Vermentino compound
showed significant cytotoxic activity at each concentration, with a 50% reduction of viability following
treatment of MCF-7 and SKBR-3 cell lines with 400 µg/mL of the hydroalcoholic extract compared to
the control (Figure 1A). Importantly, MCF-12A cells showed no reduction in viability over time with
Vermentino hydroalcoholic extract. Thus, Vermentino hydroalcoholic extract showed slight apoptotic
effects on MCF-7 and SKBR-3 breast cancer cells but not on MCF-12A epithelial breast cells.
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MCF-12A, SKBR-3, and MCF-7 cells treated with hydroalcoholic extract of Vermentino (100, 200, or 
400 µg/mL) for 16 and 24 h. The absorbance of the formazan dye was measured at 450 nm. The results 
are expressed as percentage of cell growth (%) ± SE from three independent experiments performed 
in triplicate. *p < 0.05 vs. control. Ɨp < 0.005 vs. control. (B) MCF-7 and (C) SKBR-3, 0.1 × 106 cells (6-
well plates) were plated to perform clonogenicity assay adding Vermentino hydroalcoholic extract 
for 16 and 24 h at concentrations of 100, 200, and 400 µg/mL. Photographs of the Petri dishes in a 
representative experiment are shown below the histograms. All data are expressed as colonies per 
dish in three independent experiments performed in triplicate. *p < 0.05, **p < 0.001, Ɨp < 0.0001 vs. the 
control group. 
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3.3. Vermentino Extract inhibits Clonogenicity in Breast Cancer Cell Lines
To assess the survival and proliferation of MCF-7 and SKBR-3 human breast cancer cells treated
with Vermentino hydroalcoholic leaf extract, we performed clonogenicity assays. Colony formation was
evaluated with crystal violet stain, and representative colonies are shown in Figure 1B,C. Vermentino
compound was used in concentrations of 100, 200, and 400 µg/mL for 16 and 24 h. The pure
hydroalcoholic dilutions of 200 and 400 µg/mL at 24 h were highly toxic and resulted in 48% and 80%
reductions in colony formation in MCF-7 cells, respectively, compared to control colonies (Figure 1B).
Additionally, the ethanolic dilutions of 200 and 400 µg/mL showed 39.1% and 78.3% reductions in
colony formation in SKBR-3 cells, respectively, at 24 h compared to control colonies (Figure 1C).
These results suggest that the Vermentino compound is a promising promoter of cytotoxicity in the
breast cancer cells tested.
3.4. Vermentino Extract Induced Late Apoptosis/Necrosis in Breast Cancer Cell Lines
To examine whether the cytotoxic activity of Vermentino leaf hydroalcoholic extract was due to
the induction of apoptosis, cells were exposed to 100, 200, and 400 µg/mL hydroalcoholic extract for
16 and 24 h and stained with annexin V-FITC and propidium iodide (PI) and were then analyzed
by cytofluorometry. Treatment for 16–24 h with 200 and 400 µg/mL Vermentino leaf hydroalcoholic
extract triggered a significant increase in early apoptosis in 20% of MCF-7 and SKBR-3 cells compared
to the control (Figure 2A,B). Additionally, the percentage of cell necrosis was significantly increased
compared to the control after exposure to 100 µg/mL of the leaf hydroalcoholic extract for 16 and 24 h
in MCF-7 and SKBR-3 cells (Figure 3A,B). Collectively, incubation with Vermentino leaf hydroalcoholic
extract for 24 h significantly increased late apoptotic cells by 20% and necrosis by 25% compared to
the control in both cell lines, with the greatest effect observed at a dosage of 400 µg/mL These results
indicate that treatment with Vermentino extract increases cell death via late apoptosis and necrosis in
both breast cancer cell lines.
To assess the alterations occurring after treatment with Vermentino extract, we performed an
unbiased proteomic screen by LC–MS/MS analysis to investigate which cell signaling pathways were
involved causing cytotoxicity. According to the proteomic results, most of the apoptosis pathways were
deregulated in breast cancer cell lines after treatment with Vermentino compound (Supplementary
Figure S1; Supplementary Tables S2 and S3).
3.5. Vermentino Extract Induced CASP-9 and CASP-3 in Breast Cancer Cell Lines
To further investigate the apoptotic potential of Vermentino extract on MCF-7 and SKBR-3 breast
cancer cell lines, we assessed the expression and cleavage of caspase-9 (CASP-9) and caspase-3 (CASP-3),
which are closely associated with cell death via apoptosis. As shown in Figure 3A, pro-caspase-9 protein
levels were reduced to 32% and 45% at concentrations of 200 and 400 µg/mL Vermentino hydroalcoholic
extract, respectively, after 24 h in MCF-7 cells compared to the control. Consequently, cleaved caspase-9
expression increased by 1.2 at a concentration of 400 µg/mL hydroalcoholic extract compared to
the control. Cleavage of caspase-9 implied that apoptosis was induced by Vermentino extract.
Furthermore, pro-caspase-3 activation was induced by exposure to the phytochemical hydroalcoholic
extract of Vermentino, resulting in 25% and 45% reductions of pro-caspase-3 compared to the control
at concentrations of 200 and 400 µg/mL, respectively, after 24 h. Consistent with activation of the
caspase cascade, cleaved caspase-3 was markedly increased by 2.23- and 2.2-fold at a concentration of
400 µg/mL Vermentino hydroalcoholic extract, respectively, after 24 h.
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Figure 3. Vermenti o extract induced caspase-3 (CASP-3) an ca -9) activation and
lowered fatty-acid synthase (FASN) protein level. MCF-7 an lls ere plated at a density
of 0.4 × 106 cells in 6-well plates and treated with various concentrations of hydroalcoholic extract
of Vermentino leaves (100, 200, and 400 µg/mL) for 24 h. (A) Western blot analysis of procaspase-9,
cleaved caspase-9, procaspase-3, and cleaved caspase-3 expression in hydroalcoholic extract-treated
MCF-7 and SKBR-3 cells. Densitometric ratios normalized to actin are shown below each Western blot.
Results are expressed as fold of control (mean ± SE) from five independent experiments. * p < 0.05,
** p < 0.005,
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Consistent with our observations in the MCF-7 cell line, Vermentino extract had a strong activation
effect on the caspase cascade in SKBR-3 cells. These results indicate that Vermentino hydroalcoholic
extract strongly activated pro-caspase-9, which showed a decrease of 35% at a concentration of
200 µg/mL and a decrease of 56% at a concentration of 400 µg/mL after 24 h compared to the
control. Cleaved caspase-9 showed increases of 2.4-fold at a concentration of 400 µg/mL Vermentino
hydroalcoholic extract compared to the control. Pro-caspase-3 activation was induced by exposure
to the hydroalcoholic extract of Vermentino, as evidenced by pro-caspase-3 reductions of 20% and
60% at concentrations of 200 and 400 µg/mL, respectively, after 24 h compared to the control.
Cleaved caspase-3 expression increased, implying that cell apoptosis was induced by Vermentino
phytochemical compound.
3.6. Vermentino Extract Lowers FASN Protein Level and Promoted AKT1 Signaling in Breast Cancer Cell Lines
Our proteomic analysis revealed that FASN is one of the key apoptosis-related proteins that
resulted in being downregulated by Vermentino extract (Supplementary Tables S2 and S3). Figure 3B
and Supplementary Figures S2 and S3 show the intensity of the extracted precursors isotopic envelope
(M, M + 1, M + 2) of a representative FASN peptide in control and Vermentino hydroalcoholic extract in
MCF-7 and SKBR-3 after 24 h of 400 µg/mL treatment. MCF-7 and SKBR-3 cells treated with Vermentino
hydroalcoholic extract showed 70% and 20% reductions in FASN peptide intensity, respectively.
To further confirm the effect of Vermentino leaf extract on cell apoptosis, we treated MCF-7 and
SKBR-3 cell lines with 100, 200, and 400 µg/mL hydroalcoholic extract for 24 h and examined the
protein expression of FASN, AKT1, and p-AKT1. As shown in MCF-7 cells in Figure 3C, FASN protein
levels decreased by up to 37% at the protein level at a concentration of 400 µg/mL, whereas AKT1
levels remained relatively constant compared to the control. In contrast, p-AKT1 showed an increase of
2.6- and 4.17-fold at 200 and 400 µg/mL, respectively, compared to the control. However, FASN mRNA
levels showed a slight increase of 1.2- and 1.6-fold at 200 and 400 µg/mL, respectively, compared to
the control (Figure 3C, left panel). Similar effects were observed in SKBR-3 cells (Supplementary
Figure S2B). FASN protein levels decreased by 9% and 35% at concentrations of 200 and 400 µg/mL,
respectively, whereas p-AKT1 increased by 3.6- and 4.8-fold at the same respective concentrations
compared to the control. Consistent with the data described above, SKBR-3 cells showed little variation
in protein levels of AKT1 compared to the control. However, FASN mRNA levels rose significantly in
both cell lines (Supplementary Figure S2B, left panel). Together, these results indicate that Vermentino
hydroalcoholic extract affects FASN at the level of translation rather than transcription.
In addition, proteomic analysis revealed TRAP1 (tumor necrosis factor (TNF) receptor associated
protein 1) significantly downregulated after treatment with Vermentino extract (Supplementary Tables
S2 and S3). TRAP1 is the mitochondrial member of the heat shock protein 90 (HSP90) family that
directly interacts with respiratory complexes, regulates mitochondrial permeability transition in
response to apoptotic stimuli, and mediates mitochondrial death [29].
3.7. Vermentino Extract Lowered FASN Protein Expression by Activating Proteasomal Degradation
On the basis of the observation that FASN was regulated at the post-transcriptional level and
was reduced by treatment with Vermentino extract, we next examined the protein synthesis and
degradation of FASN protein. First, we treated MCF-7 and SKBR-3 cells with 400 µg/mL Vermentino
hydroalcoholic extract for increasing amounts of time. We found that FASN levels were progressively
reduced over time. As shown in MCF-7 cells in Figure 4A, FASN protein levels fell by 16% and 26%
after 18 and 24 h of exposure, respectively, compared to the control. Similarly, FASN protein levels
decreased by 29% and 60% in SKBR-3 cells after 18 and 24 h of compound exposure, respectively,
compared to the control (Figure 4A, right panel). We went on to calculate FASN protein half-life in
MCF-7 cells, which decreased from 42.8 ± 7 h in cycloheximide (CHX)-treated samples to 23.7 ± 3 h
in CHX and Vermentino hydroalcoholic extract co-treated samples, suggesting that FASN synthesis
was not affected by Vermentino extract (Figure 4B, left panel). Interestingly, loss of FASN protein was
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significantly reduced by pretreatment with the proteasome inhibitor MG132 (Figure 4B, right panel),
indicating that protein degradation may have been impacted.
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Figure 4. Vermentino hydroalcoholic extract lowers protein stability of FASN. (A) MCF-7 and SKBR-3
cells were treated in time course with 400 µg/mL Vermentino hydroalcoholic extract. Western blotting
results are expressed as fold relative to control from three independent experiments and normalized
with β-actin. * p < 0.05. (B) FASN protein stability was determined in MCF-7 cells by cycloheximide
(CHX) and MG132 treatments when indicated, as described in the Methods section. Linear regression
equation was used to calculate half-life. Results represent mean ± SEM from three independent
experiments expressed as percentage of respective 0 h level. * p < 0.05, ** p < 0.008, N.C. 0.71 ≤ p ≤ 0.91.
(C) Ubiquitination of FASN was analyzed by immunoprecipitation. Densitometric ratios normalized
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from three independent experiments performed in triplicate. * p < 0.005 vs. control (WB). ** p < 0.01 vs.
control (IP).
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We next investigated whether FASN protein degradation was dependent on ubiquitination status.
Figure 4C shows that treatment with 400 µg/mL Vermentino hydroalcoholic extract for 24 h increased
FASN ubiquitination by threefold compared to the control. In addition, treatment with MG132
prevented Vermentino-mediated degradation of FASN protein levels in MCF-7 and SKBR-3 cell lines
and resulted in intracellular accumulation of ubiquitinated FASN.
3.8. Effects of Vermentino Extract on Proteasomal Activity
Because MG132 protected against Vermentino-induced FASN degradation, we next investigated
whether proteasomal activity was altered by treatment with the Vermentino compounds by measuring
trypsin-like (Tr-L), caspase-like (Casp-L), and chymotrypsin-like (Chym-L) proteasomal activity.
Treatment with hydroalcoholic extract for 16 and 24 h significantly decreased Tr-L activity in MCF-7
(Supplementary Figure S4A) and SKBR-3 (Supplementary Figure S5A) cell lines in a dose-dependent
manner. After 16 and 24 h of treatment, Tr-L activity was reduced most significantly when treated with
400 µg/mL of each compound in both cell lines. Neither of the Vermentino extracts had an effect on
Casp-L activity in MCF-7 (Supplementary Figure S4B) nor SKBR-3 (Supplementary Figure S5B) cell
lines. Although Chym-L activity was decreased in MCF-7 and SKBR-3 cell lines compared to controls
by 50%, there was no significant difference across doses or times (Supplementary Figures S4C and
S5C, respectively).
3.9. Vermentino Hydroalcoholic Extract Lowered UBC9 Protein Level in Human Breast Cancer Cell Lines
As no alterations in Casp-L proteasomal activity were observed with either Vermentino leaf
extract, we began investigating SUMOylation, a post-translational modification that causes proteasomal
degradation in crosstalk with ubiquitination [30]. Our proteomic data showed that the sole E2 enzyme
driving SUMOylation, ubiquitin-conjugating enzyme E2 I (UBC9), was downregulated by Vermentino
treatment in both cell lines (Supplementary Tables S2 and S3). Interestingly, UBC9 mediates the stability
of its target proteins and is upregulated in premalignant conditions [30,31]. Therefore, we evaluated the
protein level of UBC9 and found that UBC9 decreased by 80% and 50% in response to 24 h of exposure
to 400 µg/mL Vermentino hydroalcoholic extract in MCF-7 and SKBR-3 cell lines, respectively (Figure 5).
The intensity of the extracted precursor isotopic envelope (M, M + 1, M + 2) of a representative UBC9
peptide is shown in MCF-7 cells (Figure 5, top left panel) and SKBR-3 cells (Figure 5, bottom left
panel) after treatment with 400 µg/mL Vermentino hydroalcoholic extract for 24 h. MCF-7 and SKBR-3
Vermentino-treated cell lines both showed a 40% reduction in UBC9 M + 2 peptide intensity.
3.10. SUMOylation Mediated FASN Protein Stability
Modulation of protein SUMOylation or deSUMOylation modification has been associated with
regulation of carcinogenesis in breast cancer [32]. Using three different prediction software, we found
that FASN was a highly probable target for SUMOylation (Table 2), thus this led us to examine the
in vivo and in vitro SUMOylation of FASN. We found that human breast cancer tissues exhibited high
FASN SUMOylation compared to normal breast tissue (Figure 6A). Individual silencing of SUMO1,
SUMO2, and SUMO3 in MCF-7 cells did not affect FASN mRNA levels, suggesting that SUMOylation
affects FASN protein stability at the post-translational level (Figure 6B). Western blot analysis further
implicated SUMO2 in downregulation of FASN protein level. Specifically, silencing SUMO2 resulted
in a 70% drop in FASN protein level compared to control in MCF-7 cells (Figure 6C). Figure 6D
shows that treatment of MCF-7 cells with Vermentino hydroalcoholic extract for 24 h at 400 µg/mL
inhibited formation of the SUMOylation complex by lowering UBC9 protein level without affecting
SUMO2 protein expression. To provide evidence that FASN requires SUMO2 for stabilization and
protection against degradation by the proteasome, MCF-7 cells were treated with CHX for 18 and 24 h
in combination with SUMO2 silencing (Figure 6E, left panel). Co-treated cells exhibited reductions in
FASN protein levels of 70% and 80%, respectively, compared to the control. In contrast, MCF-7 cells
treated with MG132 for 18 and 24 h in combination with SUMO2 silencing did not exhibit a significant
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drop in FASN protein levels (Figure 6E, right panel). Together, these results suggest that SUMO2 is
indeed required for FASN stabilization.Biomolecules 2020, 10, x OR PEER REVIEW 15 of 23 
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level in MCF-7 and SKBR-3 cells. Cells were treated with 400 µg/mL of extract for 24 h. Total proteins
were extracted and analyzed by mass spectrometry and Western blotting UBC9 protein level. (Top and
bottom left panels) Intensity of the extracted precursor isotopic envelope (M, M + 1, M + 2) of a
representative UBC9 peptide MLFKDDYPSSPPK in MCF-7 and SKBR-3 cells treated with Vermentino
hydroalcoholic extract. All matched the theoretical isotopic distribution. (Top and bottom right panels)
Western blotting of UBC9. Densitometric ratios normalized to actin are shown below each Western blot.
Results are expressed as fold of control (mean ± SE) from five independent experiments. * p < 0.03
(MCF-7 cells), ** p < 0.05 (SKBR-3 cells) vs. control.
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Table 2. Predicted FASN small ubiquitin-like modifier (SUMO)ylation sites.
Position Sequence JASSA SUMOsp SUMOgo
K706 QELKKVIREPKPRSARWLSTS X X
K786 KPSCTIIPLMKKDHRDNLEFF X X X
K835 RGTPLISPLIKWDHSLAWDVP X X X
K1523 AFRHFLLEEDKPEEPTAHAFV X X X
K1752 DLVLNSLAEEKLQASVRCLAT X X
K2206 EASELACPTPKEDGLAQQQTQ X X X
K2471 DYNLSQVCDGKVSVHVIEGDH X XBiomolecules 2020, 10, x FOR PEER REVIEW 17 of 23 
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the SUMOylation m chinery in MCF-7 cells. (A) i munoprecipitation in 700 µg of proteins
from human breast normal (n = 3) and cancer tissues (n = 5) was blotted against UBC9. (B,C) Cells
were transfected with siSUMO-1, siSUMO-2, and siSUMO-3 for 48 h. SUMO and FASN expression
levels were analyzed by RT-PCR and Western blotting. (D) MCF-7 cells were treated with 400 µg/mL
of extract for 24 h and FASN was immunoprecipitated to analyze the complex formation with UBC9.
(E) Silencing of SUMO-2 was perform d (48 h) in co-treatment with CHX and MG132 for the last 18
and 24 h. FASN and SUMO-2 protein levels were analyzed by Western blotting. Densitometric ratios
normalized to actin and results are expressed as fold of control (mean ± SE) from three (B,E) and four
(C) independent experiments. * p < 0.01, ** p < 0.04, *** p < 0.0003, † p < 0.002 vs. Sc.
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4. Discussion
Many studies have demonstrated positive associations between cytotoxicity in cancer cells and
antioxidant activities of plant-derived compounds, such as quercetin, acid gallic, and isorhamnetin [33,34].
In this study, we evaluated the potential cytotoxic effects of the hydroalcoholic extract of Vermentino leaves.
The phenolic profile obtained by HPLC-UV analysis suggests that the Vermentino leaf extract
may have cytotoxic capability. Indeed, we found that treatment with the extract suppressed cell
viability and survival in MCF-7 and SKBR-3 breast cancer cell lines and exerted no significant effect on
MCF-12A normal breast epithelial cells. Moreover, cytofluorometric analyses suggested that breast
cancer cells were driven toward late apoptosis and necrosis in a dose- and time-dependent manner.
The involvement of the apoptotic pathway was further verified by IPA software [35], which showed
that the most affected canonical biological pathway was apoptosis.
To investigate the potential pathways underlying the cytotoxic activity, we performed proteomic
analyses on treated cells and determined that Vermentino leaf extract downregulated fatty-acid synthase
(FASN) expression at the protein level. FASN is a key enzyme in fatty-acid biosynthesis and plays an
important role in energy homeostasis via β-oxidation [36]. Lipids are the main component of the cell
membrane and are essential for cell division. Tumor cells endogenously synthesize extra fatty acids
via de novo fatty-acid synthesis, which allows them to sustain higher proliferation rates and faster
growth [37]. Inhibition of FASN induces apoptosis and creates cytotoxicity that is likely to trigger
cell death due to the accumulation of malonyl-CoA [38,39]. To evaluate the mechanism underlying
induction of apoptosis in MCF-7 and SKBR-3 cells exposed to Vermentino leaf extract, we evaluated
caspase-3 and caspase-9 activity. We found that the Vermentino leaf extract induced programmed cell
death in the breast cancer cells via modulation of the caspase-dependent pathway. Consistent with
our results, elevation of cleaved caspases is a crucial molecular target in chemoprevention [40,41].
The involvement of caspase activation in FASN-induced apoptosis was evaluated by Western blot.
We found that cleaved caspases increased in a dose-dependent manner after 16- and 24-h treatments
with Vermentino leaf extract.
FASN expression is regulated by several growth factors, including epidermal growth factor
receptor (EGFR), receptor tyrosine-kinase (ERBB2), and steroid hormone receptors (estrogen receptor,
progesterone receptor, and androgen receptor) [42]. Binding of growth factors and receptors results in
activation of the phosphoinositide 3-kinase (PI3K)-AKT transduction pathway. FASN activity and
AKT1 activation are modulated in a coregulatory pathway—FASN regulates AKT1 and activated
AKT1 regulates FASN. AKT1 activation protects cells against FASN inhibition-induced cell death
by increasing transcription of FASN [43,44]. Our data show that Vermentino leaf extract triggered
activation of AKT1 via phosphorylation as well as increased FASN mRNA levels in MCF-7 and
SKBR-3 cells. Activated AKT1 stimulates FASN expression by gene modulation of sterol regulatory
element-binding protein 1c (SREBP1C), which is a transcription factor that activates FASN by binding
to its promoter region [45]. Here, we provide evidence that increased AKT1 activation and the related
increase in FASN mRNA compensate for Vermentino-induced FASN downregulation.
To further understand the mechanism of FASN reduction, we explored two pathways: protein
synthesis and proteasomal degradation. Treatment with cycloheximide (CHX), a known protein
synthesis inhibitor, decreased FASN protein expression by locking protein turnover. However,
co-treatment with CHX and Vermentino leaf extract enhanced the reduction of FASN compared to
CHX alone, suggesting that downregulation of FASN by the compound is independent of protein
synthesis. In contrast, pretreatment with the proteasomal degradation inhibitor MG132 protected
FASN from degradation during co-treatment with Vermentino leaf extract, suggesting that the extract
downregulates FASN accumulation via activation of proteasomal degradation. Indeed, previous work
has demonstrated that treatment with chemotherapeutic agents lowers proteasomal activity of the 20s
subunit [46].
Consistent with our data, we found a downregulation of Tr-L and Chym-L activity and no
change in Casp-L activity in both cell lines, compared to controls. These results suggest that FASN
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downregulation is mediated by Casp-L activity, as Casp-L activity was not affected by Vermentino-induced
downregulation. FASN inhibitors cause the accumulation of ubiquitinated proteins through an
undetermined mechanism [47]. Similarly, Vermentino leaf extract increased the ubiquitination of
FASN. Although we observed a general reduction in proteasomal activity, affinity for the proteasomal 20s
subunit was increased and FASN degradation was promoted by proteasomal Casp-L activity.
Together, these data suggest a level of crosstalk between the fatty-acid synthesis and proteasomal
pathways whereby FASN reduction is mediated by increased ubiquitination. Therefore, Vermentino leaf
extract act to modulate FASN expression and degradation via two distinct mechanisms. The first
mechanism involves AKT1 activation, which induces transcription of FASN mRNA. The second
mechanism promotes FASN degradation via the ubiquitin-proteasome pathway. Our findings
suggest that the homeostatic balance in breast cancer cells favors the second pathway and allows
Vermentino-induced FASN degradation to outweigh the induction of FASN mRNA transcription.
Cancer cells sustain high proliferation levels by relying on de novo fatty-acid synthesis in addition to
glycolysis. Here, we demonstrated that treatment of breast cancer cells with Vermentino leaf extract altered
the levels of FASN and disrupted energetic metabolism, resulting in apoptosis. Additionally, TRAP1 (TNF
receptor associated protein 1), a molecular chaperone involved in the regulation of energetic metabolism
in several cancers [29] including breast cancer, was significantly downregulated after treatment with
Vermentino extract, in accordance with the proteomic results [28,48]. This disruption in the Warburg
phenotype [49] of cancer cells leads to increased oxygen consumption rates, which cannot be sustained and
ultimately lead to cell death. Synergistic effects of Vermentino-induced FASN and TRAP1 downregulation
may drive breast cancer cells to apoptotic cell death and exhibited no effect on normal cells.
Our proteomic analysis also revealed strong reduction in UBC9, the sole E2 enzyme that drives
SUMOylation. SUMOylation is a small ubiquitin (UB)-related modifier (SUMO) conjugation that is
similar to ubiquitination [30,31]. However, unlike ubiquitination, which normally targets proteins for
degradation, SUMOylation regulates protein stability. UBC9 is the only well-characterized E2 enzyme
in the SUMOylation cycle that transfers activated SUMO to the target protein [30]. UBC9 and SUMO are
highly expressed in human premalignant conditions in response to low-grade, long-term oxidative stress,
suggesting that up-regulation of SUMOylation may be an adaptive response to oxidative stress [31,50].
Therefore, antioxidant treatments could be expected to reduce SUMOylation levels. On the basis of
our proteomic results, we hypothesized that FASN may be a target for SUMOylation, contributing to
protein stability; in addition, it was highly predicted to be SUMOylated. Immunoprecipitation of
FASN in breast cancer cells treated with and without Vermentino extract confirmed our hypothesis
that UBC9 downregulation results in reduced SUMOylation complex formation. To understand which
SUMO protein was interacting with FASN, we silenced SUMO1, SUMO2, and SUMO3 and found that
only SUMO2 silencing reduced the FASN protein level without affecting individual SUMO expression.
This suggests that UBC9 drives SUMOylation of FASN through SUMO2 and that SUMO2 acts in a
protective mechanism to prevent FASN from being targeted for degradation. Silencing SUMO had
no effect on transcription of FASN mRNA, demonstrating that FASN downregulation occurs at the
post-translational level. To demonstrate that SUMO2 protects FASN against proteasomal degradation,
we treated the breast cancer cell lines with a protein synthesis inhibitor (CHX) and a proteasomal
degradation inhibitor (MG132) in combination with SUMO2 silencing. We found that, in combination
with CHX treatment, SUMO2 silencing reduced FASN protein levels more than SUMO2 silencing
alone. Inhibiting proteasomal degradation had no effect on FASN protein expression.
5. Conclusions
In summary, we demonstrated for the first time not only that FASN is SUMOylated, but also that
Vermentino leaf extract reduces the ability of breast cancer cells to SUMOylate FASN by lowering the
UBC9 protein level. These results provide evidence for novel therapeutic capabilities of Vermentino
leaf extract in breast cancer.
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AKT protein kinase B
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HPLC-UV high performance liquid chromatography ultraviolet
LC–MS liquid chromatography–mass spectrometry
LC-HRMS liquid chromatography high resolution mass spectrometry
MS mass spectrometry
FWHM full width at half maximum
IT injection time
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UBC9 Ubiquitin-conjugating enzyme 9
CASP-3 caspase-3
CASP-9 caspase-9
PCR polymerase chain reaction
HPRT1 hypoxanthine phosphoribosyl-transferase
MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
V-FITC annexin V fluorescein isothiocyanate
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FASTA text-based format for representing protein sequences
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Casp-L caspase-like
siRNA small interfering RNA
M precursor isotopic
PI3K phosphoinositide 3-kinase
HSP90 heat shock protein 90
TRAP-1 tumor necrosis factor receptor associated protein 1
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